Comparison of Peroral Versus Ultrathin Transnasal Endoscopy in the Diagnosis of Upper Gastrointestinal Pathology

2000 ◽  
Vol 20 (3-4) ◽  
pp. 328-330 ◽  
Author(s):  
Mohammed A. Al-Karawi ◽  
Faisal M. Sanai ◽  
Abdallah Al-Madani ◽  
Hala Kfoury ◽  
Mohammed I. Yasawy ◽  
...  
Keyword(s):  
Transnasal Endoscopy ◽  
Gastrointestinal Pathology ◽  
Upper Gastrointestinal

scholarly journals Advances in the Treatment of Gastrointestinal Bleeding: Safety and Efficiency of Transnasal Endoscopy

Medicines ◽  
2021 ◽  
Vol 8 (9) ◽  
pp. 53
Author(s):  
Hiroyuki Abe ◽  
Kenya Kamimura ◽  
Yoshihisa Arao ◽  
Junji Kohisa ◽  
Shuji Terai
Keyword(s):  
Gastrointestinal Bleeding ◽  
Esophageal Stenosis ◽  
Endoscopic Examination ◽  
New Techniques ◽  
Transnasal Endoscopy ◽  
Acute Upper Gastrointestinal Bleeding ◽  
Normal Diameter ◽  
Upper Gastrointestinal ◽  
Made In ◽  
Viable Treatment

Acute upper gastrointestinal bleeding (UGIB) is a common disorder and a gastroenterological emergency. With the development of new techniques and devices, the survivability after gastrointestinal bleeding is improving. However, at the same time, we are facing the difficulty of severely complicated cases with various diseases. For example, while endoscopic examination with a normal diameter endoscope is essential for the diagnosis and treatment of UGIB, there are several cases in which it cannot be used. In these cases, transnasal endoscopy (TNE) may be a viable treatment option. This report reviews current hemostatic devices for endoscopic treatment and the safety and efficiency of using TNE in complicated cases. The latter will be demonstrated in a case report where TNE was employed in a patient with severe esophageal stenosis. This review summarizes the advances made in the devices used and will provide further ideas for the physician in terms of combining these devices and TNE.

scholarly journals Clinico-expert diagnostics of gastrointestinal form of diabetic neuropathy

2011 ◽  
Vol 14 (2) ◽  
pp. 94-97
Author(s):  
Irina Alekseevna Kurnikova ◽  
Tatiana Evgen'evna Chernyshova ◽  
Irina Vladimirovna Gur'eva ◽  
Guzyal' Ilgisovna Kliment'eva
Keyword(s):  
Gastrointestinal Tract ◽  
Diabetic Neuropathy ◽  
Diabetic Patients ◽  
Parasympathetic Innervation ◽  
Gastric Tone ◽  
Functional Changes ◽  
Gastrointestinal Pathology ◽  
Upper Gastrointestinal

Aim. To estimate dynamics of secretory and motor-evacuational functions of the stomach in patients with type 1 diabetes mellitus and gastrointestinalform of diabetic neuropathy. Materials and methods. 32 patients with DM1 without gastrointestinal pathology allocated to different groups depending on DM duration (gr. 1 lessthan 10 yr, gr. 2 over 10 yr). Vegetative equilibrium was estimated from the Kerdo index, rehabilitative potential from its basic constituent (morphophysiologicalindex). The motor-evacuational function of the stomach was studied with the use of a scintillation gamma-chamber, the gastric secretoryfunction by pH measurements. Results. Half of the patients in gr 2 presented with hypersympathicotony. The frequency of hypertonic form of gastric tone increased with durationof DM while the acid-producing and evacuational functions of the stomach decreased (as estimated by pH-measurement and gastroscintiographyrespectively). The propulsive function most significantly decreased in the pyloric part. The efficacy of rehabilitation of diabetic patients with gastrointestinalform of diabetic neuropathy was much lower than in those with preserved vegetative function of the stomach. Conclusion. Impairment of evacuational function of the stomach and duodenum with DM1 duration may be a cause of unstable blood glucose level.Hypomotor dyskinesia of the upper gastrointestinal tract due to DM1 and deficit of parasympathetic innervation occurs more frequently in patientswith low rehabilitative potential. Functional changes in the gastrointestinal tract of DM1 patients do not depend on the quality of compensation ofmetabolic disorders but correlate (r=-0.39) with DM duration. It is concluded that the gastrointestinal form of diabetic neuropathy impairs rehabilitativepotential of fhe patients.

scholarly journals Use of anticoagulant or antiplatelet agents is not related to epistaxis in patients undergoing transnasal endoscopy

2018 ◽  
Vol 06 (01) ◽  
pp. E104-E110 ◽  
Author(s):  
Yoshiya Kobayashi ◽  
Yoshinori Komazawa ◽  
Mika Yuki ◽  
Hitomi Ishitobi ◽  
Makoto Nagaoka ◽  
...  
Keyword(s):  
Risk Factors ◽  
Antiplatelet Agents ◽  
Endoscopic Examination ◽  
Antiplatelet Drug ◽  
Antithrombotic Agent ◽  
Transnasal Endoscopy ◽  
Younger Patients ◽  
Increased Risk ◽  
Significant Difference ◽  
Upper Gastrointestinal

Abstract Background and study aims Unsedated transnasal endoscopy (uTNE) has become accepted as a safe and tolerable method for upper gastrointestinal tact examinations. Epistaxis is 1 of the major complications of TNE, though its risk factors have not been elucidated. Generally, patients administered an anticoagulant or antiplatelet drug are considered to have an increased risk of epistaxis during TNE. Here, we investigated risk factors of epistaxis in patients undergoing uTNE, with focus on those who received antithrombotic agents. Patients and methods We enrolled 6860 patients (average age 55.6 ± 12.97 years; 3405 males, 3455 females) who underwent uTNE and received the same preparations for the procedure. Epistaxis was evaluated using endoscopic images obtained while withdrawing the scope through the nostril. We also noted current use of medications including anticoagulant or antiplatelet agents prior to the endoscopic examination. Results Epistaxis occurred in 3.6 % of the enrolled patients (245/6860), and that rate was significantly higher in younger patients (average age 49.31 ± 11.8 years for epistaxis group vs. 55.83 ± 13.0 years for no epistaxis group, P < 0.01) as well as females (4.78 % vs. 2.35 %, P < 0.01). The odds ratio for occurrence of epistaxis was 2.31 (95 %CI: 1.746 – 3.167) in the younger patients and 2.02 (95 % CI: 1.542 – 2.659) in females. In contrast, there was no significant difference for rate of epistaxis between patients with and without treatment with an antithrombotic agent (3.0 % vs. 3.6 %). Conclusions The rate of epistaxis was higher in younger and female patients. Importantly, that rate was not significantly increased in patients who were administered an antithrombotic agent.

scholarly journals Unsedated Transnasal Endoscopy: A Canadian Experience in Daily Practice

2008 ◽  
Vol 22 (3) ◽  
pp. 243-246 ◽  
Author(s):  
Sarah Cho ◽  
Naveen Arya ◽  
Katherine Swan ◽  
Maria Cirocco ◽  
Gabor Kandel ◽  
...  
Keyword(s):  
Patient Satisfaction ◽  
Sore Throat ◽  
Conscious Sedation ◽  
Significant Proportion ◽  
Daily Practice ◽  
Abdominal Discomfort ◽  
Potential Cost ◽  
Transnasal Endoscopy ◽  
Per Oral ◽  
Upper Gastrointestinal

BACKGROUND: Esophagogastroduodenoscopy (EGD) is the most frequently performed diagnostic procedure for upper gastrointestinal disorders. The procedure is routinely performed under conscious sedation in North America. A significant proportion of morbidity and mortality associated with EGD is related to hypoxia due to conscious sedation. The use of sedation is also associated with an increase in cost, loss of work on the day of endoscopy and the need for the patient to be accompanied home after the procedure. Transnasal endoscopy has advantages such as no sedation and less patient monitoring, nursing time and expenses than conventional per oral EGD.OBJECTIVES: To assess the feasibility and acceptability of unsedated transnasal EGD in daily practice.METHODS: Patients due to undergo EGD were given a choice of either unsedated transnasal EGD or per oral EGD with sedation. Patients who chose unsedated transnasal EGD had the procedure performed in the office by a senior gastroenterologist with experience in transnasal EGD. All procedures were performed using a small-calibre esophagogastroduodenoscope. All patients were surveyed using a patient satisfaction questionnaire, and were asked to give specific scores in terms of choking sensation, sore throat, nasal discomfort and abdominal discomfort. All variables were assessed by scores between 0 and 10, with 10 indicating the most severe degree of each variable. Any complications were also recorded.RESULTS: Between March 2002 and August 2003, 231 patients underwent transnasal EGD. The median age of the patients was 57 years (range 15 to 87 years). Complete examinations were possible in 98% of patients. Patients reported a high degree of acceptability (mean score 6.6, range 1 to 10) and low degrees of choking sensation (mean 1.8, range 0 to 10), nasal discomfort (mean 1.7, range 0 to 10), sore throat (mean 0.8, range 0 to 9) and abdominal discomfort (mean 1.1, range 0 to 10). The only complications reported by the patients were epistaxis (n=2, 0.9%) and sinusitis (n=1, 0.4%). Some patients also reported transient light-headedness (n=12, 5%) and mucous discharge (n=2, 0.9%). When asked, 185 patients (88%) stated that they were willing to undergo the same procedure in the future if medically indicated. Of the 84 patients who had conventional EGD under conscious sedation in the past, 52 patients (62%) preferred transnasal EGD without sedation.CONCLUSIONS: Transnasal EGD is generally well tolerated, feasible and safe. It can be performed with topical anesthesia in an outpatient setting. The low complication rate, high patient satisfaction and potential cost savings make transnasal endoscopy an attractive alternative to conventional EGD to screen patients for upper gastrointestinal tract diseases.

Sign in / Sign up

Export Citation Format

Share Document